Response Evaluation Criteria in Solid Tumors

Known as: RECIST 
An internationally recognized set of published rules used for evaluation of cancer treatment that define when tumors found in cancer patients improve… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
BACKGROUND Malignant pleural mesothelioma is a highly aggressive cancer with poor prognosis and few treatment options following… (More)
Is this relevant?
Review
2017
Review
2017
Purpose We assessed the safety and antitumor activity of avelumab, a fully human anti-programmed death-ligand 1 (PD-L1) IgG1… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2015
Highly Cited
2015
LBA100 Background: Somatic mutations have the potential to be recognized as "non-self" immunogenic antigens. Tumors with genetic… (More)
Is this relevant?
Highly Cited
2012
Highly Cited
2012
PURPOSE This phase I dose-escalation study investigated the maximum-tolerated dose (MTD), safety, preliminary activity… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Most treatments for patients with metastatic melanoma have a low rate of complete regression and thus overall survival in… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Adoptive immunotherapy using tumor-infiltrating lymphocytes represents an effective cancer treatment for patients with… (More)
  • table 1
  • table 2
  • figure 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Immunotherapeutic agents produce antitumor effects by inducing cancer-specific immune responses or by modifying native… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Evaluation of response to treatment is a key aspect in cancer therapy. Response Evaluation Criteria in Solid Tumors… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE The two approved treatments for patients with metastatic melanoma, interleukin (IL)-2 and dacarbazine, mediate objective… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Response Evaluation Criteria in Solid Tumors (RECIST) are insensitive in evaluating gastrointestinal stromal tumors… (More)
  • table 1
  • table 2
  • table 3
  • figure 2
  • figure 1
Is this relevant?